Controversies in the management of hyperglycemia in the ELBW infant

Indian Pediatrics

Volumn 45, Issue 1, 2008, Pages 29-38

  Kairamkonda, V R ^a   Khashu, Minesh ^b,c  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Extremely low birth weight infants; Glucosuria; Hyperglycemia; Insulin

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; INSULIN; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2;

CLINICAL TRIAL; DISEASE CONTROL; EXTREMELY LOW BIRTH WEIGHT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN TREATMENT; INTENSIVE CARE; NEWBORN DISEASE; OSMOREGULATION; PATHOPHYSIOLOGY; REVIEW; TREATMENT INDICATION;

ALGORITHMS; BLOOD GLUCOSE; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN; PRACTICE GUIDELINES AS TOPIC;

EID: 38348999370     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Kao LS, Morris BH, Lally KP, Stewart CD, Huseby V, Kennedy KA. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006; 26: 730-736.
2. Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006; 118: 1811-1818.
3. Hawdon JM. Disorders of blood glucose homoestasis in the neonate. In: Rennie JM, Roberton NRC, ed. Textbook of Neonatology, 4th ed. London: Elsevier Churchill Livingstone; 2005. p. 862-865.
4. Hay WW Jr. Addressing hypoglycemia and hyperglycemia. Pediatr Rev 1999; 20: e4-e5.
5. Hey E. Hyperglycemia and the very preterm baby. Semin Fetal Neonat Med 2005; 10: 377-387.
6. Cornblath M, Schwartz R. Disorders of Carbohydrate Metabolism in Infancy. 2nd ed. Philadelphia, PA: WB Saunders; 1976.
7. Hemachandra AH, Cowett RM. Neonatal hyperglycemia. Pediatr Rev 1999; 20: e16-e24.
8. Brion LP, Satlin LM. Clinical Significance of Developmental Renal Physiology. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology, 2nd ed, Philadelphia, PA: WB Saunders Company; 1998. p. 1680-1691.
9. Coulthard MG, Hey EN. Renal processing of glucose in well and sick neonates. Arch Dis Child Fetal Neonatal Ed 1999; 81: F92-98.
10. Newman JD, Pecache NS, Barfield CP, Balazs ND. Point-of-care testing of blood glucose in the neonatal unit using the AVL Omni 9 analyser. Ann Clin Biochem 2002; 39(Pt 5): 509-512.
11. Khan AI, Vasquez Y, Gray J, Wians FH Jr, Kroll MH. The variability of results between point-ofcare testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med 2006; 130: 1527-1532.
12. Tura A, Maran A, Pacini G. Non-invasive glucose monitoring: assessment of technologies and devices according to quantitative criteria. Diabetes Res Clin Pract 2007; 77: 16-40.
13. Dweck HS, Cassady G. Glucose intolerance in infants of very low birth weight. Incidence of hyperglycemia in infants of birth weight 1100 grams or less. Pediatrics 1974; 53: 184-195.
14. Binder ND, Raschko PK, Benda GI, Reynolds JW. Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia. J Pediatr 1989; 114: 273-280.
15. Thureen PJ. Early aggressive nutrition in the neonate. Neo Rev 1999; 44: e45-e55.
16. Hume R, Burchell A, Williams FL, Koh DK. Glucose homeostasis in the newborn. Early Hum Dev 2005; 81: 95-101.
17. Karp TB, Scardino C, Butler LA. Glucose metabolism in the neonate: the short and sweet of it. Neonatal Netw 1995; 14: 17-23.
18. Cowett RM. Hypoglycemia and Hyperglycemia in the Newborn. In: Polin RA, Fox WW, eds. Fetal and neonatal physiology, 2nd ed, Philadelphia, PA: WB Saunders Company; 1998. p. 602-608.
19. Ditzenberger GR, Collins SD, Binder N. Continuous insulin intravenous infusion therapy for VLBW infants. J Perinat Neonatal Nurs 1999; 13: 70-82.
20. Mena P, Llanos A, Uauy R. Insulin homeostasis in the extremely low birth weight infant. Semin Perinatol 2001; 25: 436-446.
21. Mitanchez-Mokhtari D, Lahlou N, Kieffer F, Magny JF, Roger M, Voyer M. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics 2004; 113: 537-541.
22. Savich RD, Finley SL, Ogata ES. Intravenous lipid and amino acids briskly increase plasma glucose concentrations in small premature infants. Am J Perinatol 1988; 5: 201-205.
23. Uldry M, Thorens B. The SLC2 family or facilitated hexose and polyol transporters. Pflugers Arch 2004; 447: 480-489.
24. Wright EM, Turk E. The sodium glucose cotransport family SLC5. Pflugers Arch 2004; 447: 510-518.
25. Shield JP. Neonatal diabetes: new insights into aetiology and implications. Horm Res 2000; 53 Suppl 1: 7-11.
26. Metz C, Cave H, Bertrand AM, Deffert C, Gueguen-Giroux B, Czernichow P, et al. Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 2002; 141: 483-489.
27. Finberg L. Dangers to infants caused by changes in osmolal concentration. Pediatrics 1967; 40: 1031-1034.
28. Zhang JZ, Jing L, Ma AL, Wang F, Yu X, Wang YL. Hyperglycemia increased brain ischemia injury through extracellular signal-regulated protein Kinase. Pathol Res Pract 2006; 202: 31-36.
29. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
30. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005; 146: 30-34.
31. Ertl T, Gyarmati J, Gaal V, Szabo I. Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 2006; 89: 56-59.
32. Eriksson UJ, Borg LA, Cederberg J, Nordstrand H, Siman CM, Wentzel C, et al. Pathogenesis of diabetes-induced congenital malformations. Ups J Med Sci 2000; 105: 53-84.
33. American Academy of Pediatrics, Committee on Nutrition. Nutritional needs of preterm infants. In: Kleinman R (ed). Pediatric Nutrition Handbook. Elk Grove Village, IL: American Academy of Pediatrics; 1998. p. 55-87.
34. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ 1998; 317: 1481-1487.
35. Collins JW, Hoppe M, Brown K, Edidin DV, Padbury J, Ogata ES. A controlled trial of insulin and parenteral nutrition in extremely low birth weight infants with glucose intolerance. J Pediatr 1991; 118: 921-927.
36. Meetze W, Bowsher R, Compton J, Moorehead H. Hyperglycemia in extremely-low-birth-weight infants. Biol Neonate 1998; 74: 214-221.
37. Zylberberg R, Pepper M. Continuous insulin infusion: promoting growth in low birth weight infants. Neonatal Netw 2001; 20: 17-24.
38. Simeon PS, Gottesman MM. Neonatal continuous insulin infusion: A survey of ten level III nurseries in Los Angeles County. Neonat Netw 1991; 9: 19-25.
39. Gibson AT, Carney S, Cavazzoni E, Wales JK. Neonatal and postnatal growth. Horm Res 2000; 53 suppl 1: 42-49.
40. Morley R, Lucas A. Influence of early diet on outcome in preterm infants. Acta Pediatr 1994; 405: 123-126.
41. Vaucher YE, Walson PD, Morrow G 3rd. Continuous insulin infusion in hyperglycemic, very low birth weight infants. J Pediatr Gastroenterol Nutr 1982; 1: 211-217.
42. Ostertag SG, Jovanovic L, Lewis B, Auld PA. Insulin pump therapy in the very low birth weight infant. Pediatrics 1986; 78: 625-630.
43. Heron P, Bourchier D. Insulin infusions in infants of birthweight less than 1250 g and with glucose intolerance. Aust Paediatr J 1988; 24: 362-365.
44. Kanarek KS, Santeiro ML, Malone JI. Continuous infusion of insulin in hyperglycemic low-birth weight infants receiving parenteral nutrition with and without lipid emulsion. J Parenter Enteral Nutr 1991; 15: 417-420.
45. Thabet F, Bourgeois J, Guy B, Putet G. Continuous insulin infusion in hyperglycaemic very-low-birth-weight infants receiving parenteral nutrition. Clin Nutr 2003; 22: 545-547.
46. Ng SM, May JE, Emmerson AJ. Continuous insulin infusion in hyperglycaemic extremely-low-birth-weight neonates. Biol Neonate 2005; 87: 269-272.
47. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M, et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51: 540-544.
48. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002; 49: 531-537.
49. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.
50. Malmberg K. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314: 1512-1515.
51. Garofano A, Czernichow P, Breant B. Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 1998; 41: 1114-1120.
52. Aynsley-Green A, Hawdon JM, Deshpande S, Platt MW, Lindley K, Lucas A. Neonatal insulin secretion: implications for the programming of metabolic homeostasis. Acta Paediatr Jpn 1997; 39 Suppl 1: S21-25.
53. Lucas A, Bloom SR, Aynsley-Green A. Gut hormones and "minimal enteral feedings". Acta Paediatr Scand 1986; 75: 719-723.
54. Berseth CL. Effect of early feeding on maturation of the preterm infant's small intestine. J Pediatr 1992; 120: 947-953.
55. De La Puente A, Goya L, Ramos S, Martin MA, Alvarez C, Escriva F, et al. Effects of experimental diabetes on renal IGF/IGFBP system during neonatal period in the rat. Am J Physiol Renal Physiol 2000; 279: F1067-F1076.
56. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the new-born. J Clin Endocrinol Metab 1998; 83: 3550-3557.
57. Hellstrom A, Carlsson B, Niklasson A, Hellstrom A, Carlsson B, Niklasson A, et al. IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 2002; 87: 3413-3416.
58. Corallo C, Dooley M, Sitaram BR. Determination of insulin concentrations in plastic infusion systems. Aust J Hosp Pharm 1995; 25: 129-135.
59. Lucas A. Programming by early nutrition in man. Ciba Found Symp 1991; 156: 38-55.
60. Barker DJP. The developmental origins of chronic adult disease. Acta Pediatr Suppl 2004; 93: 26-33.